3 FDA approval dates to watch in the year’s final push

In terms of novel drugs, FDA approvals spiked in 2023 to 55 new treatments (up from 37 in 2022). So far this year, the agency has OK’d 29.

Still, several drug candidates are scheduled for review by the FDA for potential approval in the coming months, including novel drugs and indication expansions that could widen the market and offer breakthroughs in different disease areas.